Abstract
IntroductionPatients with metastatic or locally advanced, non-resectable, grade 3 poorly differentiated gastroenteropancreatic (GEP) and lung neuroendocrine carcinomas (NECs) are usually treated with in first-line platinum compounds. There is no standard...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have